Skip to main content

Advertisement

SpringerLink
Log in

A Review of Advances in Collaborative Pharmacy Practice to Improve Adherence to Standards of Care in Diabetes Management

  • Health Care Delivery Systems in Diabetes (D Wexler, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

The prevalence of diabetes in the United States is increasing and so is the need to provide diabetes care. Given the time commitment and complexity of diabetes management, an interdisciplinary approach is recommended. Pharmacists are integral members of the diabetes care team because of their accessibility and expertise in medication management. Pharmacists are receiving specialized training and becoming more involved in direct patient care through collaborative practice opportunities such as medication therapy management and collaborative drug therapy management. These collaborative practice models increase patient access to care and allow pharmacists to optimize drug therapy and provide important education to promote diabetes self-management. Studies show pharmacists practicing in a variety of outpatient environments can reduce HbA1c, LDL and BP as well as improve adherence to recommended American Diabetes Association guidelines (yearly monofilament exams, dilated eye exams, microalbumin screening, etc). Pharmacists working as part of the health care team can ensure optimal diabetes management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance.

  1. Number (in millions) of civilian, noninstitutionalized persons with diagnosed diabetes, United States, 1980-2011. http://www.cdc.gov/diabetes/statistics/prev/national/figpersons.htm. Updated 2013. Accessed August 20, 2013.

  2. American Diabetes Association. Economic costs of diabetes in the US in 2012. Diabetes Care. 2013;36:1033–46.

    Article  Google Scholar 

  3. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National estimates and general information on diabetes and prediabetes in the United States, 2011. US Department of Health and Human Services. 2011.

  4. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2013;36 Suppl 1:S11–66.

    Article  PubMed Central  Google Scholar 

  5. U.S. Department of Health and Human Services. The Physician Workforce: projections and research into current issues affecting supply and demand. 2008 (August 22). http://bhpr.hrsa.gov/healthworkforce/reports/physwfissues.pdf.

  6. Petterson SM, Phillips Jr RL, Bazemore AW, Burke BT, Koinis GT. Relying on NPs and PAs does not avoid the need for policy solutions for primary care. Am Fam Physician. 2013;88:230.

    PubMed  Google Scholar 

  7. Ohio Pharmacists Association. Office of surgeon general recognizes pharmacists' effectiveness. http://www.osae.org/aws/OPA/pt/sd/news_article/55219/_PARENT/layout_interior_details/true. Updated 2013. Accessed August 29, 2013.

  8. Giberson S, Yoder S, Lee M. Improving patient and health system outcomes through advanced pharmacy practice. A report to the US Surgeon General. Office of the Chief Pharmacist. US Public Health Service. 2011.

  9. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–43.

    CAS  PubMed  Google Scholar 

  10. Cranor CW, Bunting BA, Christensen DB. The Asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173–84.

    Article  Google Scholar 

  11. Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc. 2005;45:566–72.

    Article  Google Scholar 

  12. Drug MP. Improvement, and modernization act of 2003. Public Law. 2003;108:173.

    Google Scholar 

  13. Medication therapy management; Centers for Medicare & Medicaid Services web site. http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/MTM.html. Published 10 April 2013. Updated 2013. Accessed July 22, 2013.

  14. Tudor C. CY 2013 Medication therapy management program guidance and submission instructions. http://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/Downloads/Memo-Contract-Year-2013-Medication-Therapy-Management-MTM-Program-Submission-v041012.pdf. Updated 2012. Accessed August 13, 2013.

  15. Barnett MJ, Frank J, Wehring H, et al. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years. J Manag Care Pharm. 2009;15:18–31.

    PubMed  Google Scholar 

  16. Jennings BT, Marx CM. Implementation of a pharmacist-managed diabetes program. Am J Health Syst Pharm. 2012;69:1951–3. doi:10.2146/ajhp120252.

    Article  PubMed  Google Scholar 

  17. Garrett DG, Bluml BM. Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc. 2005;45:130–7.

    Article  Google Scholar 

  18. Doucette WR, Witry MJ, Farris KB, McDonough RP. Community pharmacist-provided extended diabetes care. Ann Pharmacother. 2009;43:882–9.

    Article  PubMed  Google Scholar 

  19. Pinto SL, Bechtol RA, Partha G. Evaluation of outcomes of a medication therapy management program for patients with diabetes. J Am Pharm Assoc. 2012;52:519–23. doi:10.1331/JAPhA.2012.10098.

    Article  Google Scholar 

  20. Planas LG, Crosby KM, Mitchell KD, Farmer KC. Evaluation of a hypertension medication therapy management program in patients with diabetes. J Am Pharm Assoc. 2009;49:164.

    Article  Google Scholar 

  21. Ramalho de Oliveira D, Brummel AR, Miller DB. Medication therapy management: 10 years of experience in a large integrated health care system. J Manag Care Pharm. 2010;16:185–95. This study highlights the impact of MTM services provided over a decade in a large health system where pharmacists identified drug therapy problems to improve clinical outcomes and cost savings.

    PubMed  Google Scholar 

  22. Isetts BJ, Schondelmeyer SW, Artz MB, et al. Clinical and economic outcomes of medication therapy management services: the Minnesota experience. J Am Pharm Assoc. 2008;48:203–14.

    Article  Google Scholar 

  23. Irons BK, Seifert CF, Horton NA. Quality of care of a pharmacist-managed diabetes service compared with usual care in an indigent clinic. Diabetes Technol Ther. 2008;10:220–6.

    Article  CAS  PubMed  Google Scholar 

  24. Enfinger F, Campbell K, Taylor JR. Collaboration with pharmacy services in a family practice for the medically underserved. Pharm Pract. 2009;7:248–53.

    Google Scholar 

  25. McCord AD. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacotherapy. 2006;26:248–53. doi:10.1592/phco.26.2.248.

    Article  PubMed  Google Scholar 

  26. Machado M, Bajcar J, Guzzo GC, Einarson TR. Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management. Ann Pharmacother. 2007;41:1569–82.

    Article  PubMed  Google Scholar 

  27. Kucukarslan SN, Hagan AM, Shimp LA, Gaither CA, Lewis NJ. Integrating medication therapy management in the primary care medical home: a review of randomized controlled trials. Am J Health Syst Pharm. 2011;68:335–45.

    Article  PubMed  Google Scholar 

  28. Rothman RL, Malone R, Bryant B, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med. 2005;118:276–84.

    Article  PubMed  Google Scholar 

  29. Rothman RL, DeWalt DA, Malone R, et al. Influence of patient literacy on the effectiveness of a primary care–based diabetes disease management program. JAMA. 2004;292:1711–6.

    Article  CAS  PubMed  Google Scholar 

  30. Berdine HJ, Skomo ML. Development and integration of pharmacist clinical services into the patient-centered medical home. J Am Pharm Assoc. 2012;52:661–7. doi:10.1331/JAPhA.2012.10206. This article demonstrates how a pharmacist can provide MTM in a PCMH setting. Significant improvements were seen in HbA1c, lipids, and BMI.

    Article  Google Scholar 

  31. Choe HM, Mitrovich S, Dubay D, Hayward RA, Krein SL, Vijan S. Proactive case management of high-risk patients with type 2 diabetes mellitus by a clinical pharmacist: a randomized controlled trial. Am J Manage Care. 2005;11:253–60.

    Google Scholar 

  32. Johnson KA, Chen S, Cheng IN, et al. The impact of clinical pharmacy services integrated into medical homes on diabetes-related clinical outcomes. Ann Pharmacother. 2010;44:1877–86. doi:10.1345/aph.1P380. This study demonstrated the significance of a clinical pharmacist providing MTM services while integrated into a primary care team of a medical home. Improved clinical outcomes in diabetes management were observed, including HbA1c, lipids, BP, and BMI.

    Article  PubMed  Google Scholar 

  33. Prevention and public health fund (PPHF) strategy and implementation office. http://www.cdc.gov/fmo/topic/PPHF/index.html. Updated 2012. Accessed August 22, 2013.

  34. Place of influenza vaccination among adults—United States, 2010—11 influenza season. Centers for Disease Control and Prevention. Morbidity and Mortality Weekly Report Web site. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6023a3.htm. Updated 2011. Accessed August 22, 2013.

  35. American Society of Health-System Pharmacists. ASHP statement on the role of health-system pharmacists in public health. Am J Health-Syst Pharm. 2008;65:462–7.

    Google Scholar 

  36. Armor BL, Britton ML, Dennis VC, Letassy NA. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010;23:250–64. doi:10.1177/0897190009336668. This article provides an extensive review of primary literature that highlights the impact clinical pharmacists have had on patients with diabetes in various collaborative practice environments from 1960-2008. This review article summarizes the key outcomes and services provided from each trial.

    Article  PubMed  Google Scholar 

  37. Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacists—2003. Pharmacotherapy. 2003;23:1210–25.

    Article  PubMed  Google Scholar 

  38. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28:421–36. doi:10.1592/phco.28.4.421.

    Article  PubMed  Google Scholar 

  39. Haas L, Maryniuk M, Beck J, et al. National standards for diabetes self-management education and support. Diabetes Care. 2013;36 Suppl 1:S100–8. doi:10.2337/dc13-S100; 10.2337/dc13-S100.

    Article  PubMed Central  PubMed  Google Scholar 

  40. Coast-Senior EA, Kroner BA, Kelley CL, Trilli LE. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother. 1998;32:636–41.

    Article  CAS  PubMed  Google Scholar 

  41. Cioffi ST, Caron MF, Kalus JS, Hill P, Buckley TE. Glycosylated hemoglobin, cardiovascular, and renal outcomes in a pharmacist-managed clinic. Ann Pharmacother. 2004;38:771–5. doi:10.1345/aph.1D359.

    Article  PubMed  Google Scholar 

  42. Leal S, Glover JJ, Herrier RN, Felix A. Improving quality of care in diabetes through a comprehensive pharmacist-based disease management program. Diabetes Care. 2004;27:2983–4.

    Article  PubMed  Google Scholar 

  43. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother. 1996;30:238–43.

    CAS  PubMed  Google Scholar 

  44. Letassy N, Armor B, Britton M, Farmer K. Pharmacist-managed diabetes service in a family medicine practice improves patient outcomes. Drug Benefit Trends. 2003;15:21–32.

    Google Scholar 

  45. Nowak SN, Singh R, Clarke A, Campbell E, Jaber LA. Metabolic control and adherence to American Diabetes Association practice guidelines in a pharmacist-managed diabetes clinic. Diabetes Care. 2002;25:1479.

    Article  PubMed  Google Scholar 

  46. Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39:433–40. doi:10.1345/aph.1E438.

    Article  PubMed  Google Scholar 

  47. Felt-Lisk S, Mays G, Harris L, Lee M, Nyman R, Smieliauskas F. Evaluation of HRSA’s clinical pharmacy demonstration projects. Vol. I: Synthesis Report. Washington, DC: Mathematica Policy Research, Inc. 2004.

  48. Irons BK, Lenz RJ, Anderson SL, Wharton BL, Habeger B, Anderson Jr HG. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic. Pharmacotherapy. 2002;22:1294–300.

    Article  PubMed  Google Scholar 

  49. Ragucci KR, Fermo JD, Wessell AM, Chumney EC. Effectiveness of pharmacist-administered diabetes mellitus education and management services. Pharmacotherapy. 2005;25:1809–16. doi:10.1592/phco.2005.25.12.1809.

    Article  PubMed  Google Scholar 

  50. Kelly C, Rodgers PT. Implementation and evaluation of a pharmacist-managed diabetes service. J Manag Care Pharm. 2000;6:488–93.

    Google Scholar 

  51. Shane-McWhorter L, Oderda GM. Providing diabetes education and care to underserved patients in a collaborative practice at a Utah community health center. Pharmacotherapy. 2005;25:96–109. doi:10.1592/phco.25.1.96.55623.

    Article  PubMed  Google Scholar 

  52. Davidson MB, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual. 2000;15:137–42.

    Article  CAS  PubMed  Google Scholar 

  53. Brooks AD, Rihani RS, Derus CL. Pharmacist membership in a medical group's diabetes health management program. Am J Health Syst Pharm. 2007;64:617–21. doi:10.2146/ajhp060095.

    Article  PubMed  Google Scholar 

  54. Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39:1828–32. doi:10.1345/aph.1G356.

    Article  PubMed  Google Scholar 

  55. Padiyara RS, D'Souza JJ, Rihani RS. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group. J Manag Care Pharm. 2011;17:456–62.

    PubMed  Google Scholar 

  56. Jacobs M, Sherry PS, Taylor LM, Amato M, Tataronis GR, Cushing G. Pharmacist assisted medication program enhancing the regulation of diabetes (PAMPERED) study. J Am Pharm Assoc. 2012;52:613–21. doi:10.1331/JAPhA.2012.10183. This randomized prospective trial is a model example of how clinical pharmacists can be integrated into a primary care team. Though not practicing under a formal CDTM agreement during the study period, clinical pharmacist interventions still improved diabetes outcome measures.

    Article  Google Scholar 

  57. Salvo MC, Brooks AM. Glycemic control and preventive care measures of indigent diabetes patients within a pharmacist-managed insulin titration program vs standard care. Ann Pharmacother. 2012;46:29–34. doi:10.1345/aph.1Q512. This retrospective cohort study is an example of how a pharmacist managed insulin titration program under a CDTM agreement can improve HbA1c levels and preventative care measures. This study highlights key benefits of a collaborative practice involving a pharmacist; increased access to care, frequent monitoring, optimizing drug therapy, and improvement in diabetes related outcomes.

    Article  PubMed  Google Scholar 

  58. Rochester CD, Leon N, Dombrowski R, Haines ST. Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus. Am J Health Syst Pharm. 2010;67:42–8. doi:10.2146/ajhp080706.

    Article  CAS  PubMed  Google Scholar 

  59. Sease JM, Franklin MA, Gerrald KR. Pharmacist management of patients with diabetes mellitus enrolled in a rural free clinic. Am J Health Syst Pharm. 2013;70:43–7. doi:10.2146/ajhp120221. This article highlights a pharmacist managed diabetes clinic in which the pharmacist was the only practitioner adjusting medications for diabetes, lipids, and blood pressure.

    Article  PubMed  Google Scholar 

  60. Ip EJ, Shah BM, Yu J, Chan J, Nguyen LT, Bhatt DC. Enhancing diabetes care by adding a pharmacist to the primary care team. Am J Health Syst Pharm. 2013;70:877–86. doi:10.2146/ajhp120238.

    Article  CAS  PubMed  Google Scholar 

  61. Jameson JP, Baty PJ. Pharmacist collaborative management of poorly controlled diabetes mellitus: a randomized controlled trial. Am J Manage Care. 2010;16:250–5.

    Google Scholar 

  62. Pepper MJ, Mallory N, Coker TN, Chaki A, Sando KR. Pharmacists' impact on improving outcomes in patients with type 2 diabetes mellitus. Diabetes Educ. 2012;38:409–16. doi:10.1177/0145721712443291.

    Article  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Michael P. Conley declares that he has no conflict of interest. Christine Chim declares that she has no conflict of interest. Chelsea E. Magee declares that she has no conflict of interest. Daniel J. Sullivan declares that he has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Bouvé College of Health Sciences, School of Pharmacy, Northeastern University, 360 Huntington Ave – R218 TF, Boston, MA, 02115, USA

    Michael P. Conley, Chelsea E. Magee & Daniel J. Sullivan

  2. College of Pharmacy & Health Sciences, St. John’s University, 8000 Utopia Parkway, Queens, NY, 11439, USA

    Christine Chim

Authors
  1. Michael P. Conley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christine Chim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chelsea E. Magee
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daniel J. Sullivan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael P. Conley.

Additional information

This article is part of the Topical Collection on Health Care Delivery Systems in Diabetes

Rights and permissions

Reprints and permissions

About this article

Cite this article

Conley, M.P., Chim, C., Magee, C.E. et al. A Review of Advances in Collaborative Pharmacy Practice to Improve Adherence to Standards of Care in Diabetes Management. Curr Diab Rep 14, 470 (2014). https://doi.org/10.1007/s11892-013-0470-0

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-013-0470-0

Keywords

Search

Navigation